151 related articles for article (PubMed ID: 183980)
21. [Hypolipidemic activity of trimethylglycine].
Kliueva NN; Kalashnikova NM; Okunevich IV; Sapronov NS
Eksp Klin Farmakol; 2012; 75(1):16-8. PubMed ID: 22442957
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia.
Aoki T; Yamazaki H; Suzuki H; Tamaki T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2001; 51(3):197-203. PubMed ID: 11304935
[TBL] [Abstract][Full Text] [Related]
23. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
Timms AR; Kelly LA; Ho RS; Trapold JH
Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
[No Abstract] [Full Text] [Related]
24. Antihyperlipidemic activity of Cassia auriculata flowers in triton WR 1339 induced hyperlipidemic rats.
Vijayaraj P; Muthukumar K; Sabarirajan J; Nachiappan V
Exp Toxicol Pathol; 2013 Jan; 65(1-2):135-41. PubMed ID: 21852078
[TBL] [Abstract][Full Text] [Related]
25. Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
Jahromi MA; Ray AB
J Nat Prod; 1993 Jul; 56(7):989-94. PubMed ID: 8377021
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological study of nine antimicrotubular drugs with acrylophenone structure on Triton WR 1339-induced hyperlipidemia in rats.
Brunet C; Luyckx M; Cazin M; Lesieur I; Lesieur D; Lespagnol C; Delacourte A; Mallevais ML
Methods Find Exp Clin Pharmacol; 1985 Nov; 7(11):579-83. PubMed ID: 4087977
[TBL] [Abstract][Full Text] [Related]
27. 3-Alkyl-3-hydroxyglutaric acids: a new class of hypocholesterolemic HMG CoA reductase inhibitors. 1.
Baran JS; Laos I; Langford DD; Miller JE; Jett C; Taite B; Rohrbacher E
J Med Chem; 1985 May; 28(5):597-601. PubMed ID: 3989819
[TBL] [Abstract][Full Text] [Related]
28. Protective role of puerarin on lead-induced alterations of the hepatic glutathione antioxidant system and hyperlipidemia in rats.
Liu CM; Ma JQ; Sun YZ
Food Chem Toxicol; 2011 Dec; 49(12):3119-27. PubMed ID: 22001170
[TBL] [Abstract][Full Text] [Related]
29. Influence of atorvastatin on fractional and subfractional composition of serum lipoproteins and MMP activity in mice with Triton WR 1339-induced lipaemia.
Korolenko TA; Cherkanova MS; Tuzikov FV; Johnston TP; Tuzikova NA; Loginova VM; Kaledin VI
J Pharm Pharmacol; 2011 Jun; 63(6):833-9. PubMed ID: 21585382
[TBL] [Abstract][Full Text] [Related]
30. Isolation of bioactive phytoconstituent from Alpinia galanga L. with anti-hyperlipidemic activity.
Iyer D; Sharma BK; Patil UK
J Diet Suppl; 2013 Dec; 10(4):309-17. PubMed ID: 24168404
[TBL] [Abstract][Full Text] [Related]
31. Dissolution of gallstones in hamsters by 3-hydroxy-3-methylglutaric acid.
Kritchevsky D; Story JA; Klurfeld DM
Experientia; 1978 Oct; 34(10):1328. PubMed ID: 738409
[TBL] [Abstract][Full Text] [Related]
32. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.
Schurr PE; Schultz JR; Parkinson TM
Lipids; 1972 Jan; 7(1):68-74. PubMed ID: 5013174
[No Abstract] [Full Text] [Related]
33. Effect of probucol on triton induced hyperlipidemias in CFY rats.
Krishnamurthy A; Thapar GS; Shridhar DR
Artery; 1985; 13(2):87-94. PubMed ID: 4084069
[TBL] [Abstract][Full Text] [Related]
34. Effect of bezafibrate & nicotinic acid on triton induced hyperlipidemias in CFY rats.
Krishnamurthy A; Thapar GS
Indian J Med Res; 1991 Oct; 94():395-8. PubMed ID: 1794899
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
36. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
[TBL] [Abstract][Full Text] [Related]
37. Hypolipidemic effect of β-caryophyllene to treat hyperlipidemic rats.
Baldissera MD; Souza CF; Grando TH; Doleski PH; Boligon AA; Stefani LM; Monteiro SG
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):215-223. PubMed ID: 27913825
[TBL] [Abstract][Full Text] [Related]
38. Serum and tissue lipid metabolism and effect of nicotinic acid in different types of hyperlipidemia.
Carlson LA; Walldius G
Adv Exp Med Biol; 1972; 26(0):165-78. PubMed ID: 4370366
[No Abstract] [Full Text] [Related]
39. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
Kalaiarasi P; Kaviarasan K; Pugalendi KV
Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of ethyl 6-substituted-chroman- and -chromone-2-carboxylates. A comparative structure-activity study employing the 6-phenyl and phenoxy analogs in the triton hyperlipidemic rat model.
Witiak DT; Heilman WP; Sankarappa SK; Cavestri RC; Newman HA
J Med Chem; 1975 Sep; 18(9):935-42. PubMed ID: 1159716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
